Navigation Links
Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study
Date:9/27/2011

PONTE VEDRA BEACH, Fla., Sept. 27, 2011 /PRNewswire/ -- Nuance Health today announced the results of an eight-week clinical study that was conducted on their innovative product, Swype Cold & Flu Shield, during the 2010-11 cold and flu season.  

The clinical study, conducted on 103 volunteers who identified themselves as typically susceptible to colds, evaluated the effectiveness, tolerability, and willingness of participants to use a nasal gel to prevent illness.  In previous testing performed by an independent microbiology laboratory, the active ingredients in Swype have been shown to kill over 99.9% of all 25 cold and flu viruses tested including 15 serotypes of rhinovirus and swine influenza (H1N1).  In the study, participants were instructed to use Swype three times daily for eight weeks during the cold and flu season.  The volunteers reported actual use of the product and cold symptoms via weekly email surveys.

The results of the clinical study were outstanding.  Over 83% of volunteers used Swype two or three times per day during the study, an excellent compliance rate for a prophylactic product (fewer people wash their hands after using the bathroom).  In a typical cold and flu season, about 45% of participants would have experienced moderate or stronger cold symptoms during an eight-week period, but only 2% of Swype users reported more than mild cold symptoms.  Overall, users of Swype experienced about 70% fewer colds than anticipated, an unprecedented result for a cold prevention product.

Volunteers in the study offered unprompted praise for Swype Cold & Flu Shield: "I love Swype and tell many about your product," "Overall the product is invisible, light, and easy to use," "Everyone around me is sick, but not me," and "I actually had a cold when I started using Swype and within one day it was gone" are examples of comments posted by Swype users.

"I am very excited about the results of this study," said Dr. Kent New, the creator of Swype and a physician with a PhD in Microbiology and Immunology.  "No other cold prevention product on the market has results comparable to what we have been able to demonstrate with Swype.  By using Swype to kill virus on the skin at the entrance to your nose, you are significantly reducing the chance you catch a cold or flu.  In addition, about 85% of participants reported they would continue to use the product and recommend it to friends, indicating Swype is easy to use and effective."

Swype Cold & Flu Shield is available on the Swype website (www.SwypeForHealth.com).  A tube that lasts approximately 2 months costs $12.99.  Nuance Health is currently offering 20% off orders by using code "CLIN20".  

For more information about Swype, visit www.SwypeForHealth.com.

About Nuance Health

Nuance Health was started by a physician and his wife. Together, they use their understanding of science to develop safe and effective products that help people maintain good health.  

CONTACT INFORMATION:
Jim McDonald
877-367-7997 x704
Jim@NuanceHealth.com


'/>"/>
SOURCE Nuance Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu
2. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
3. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
6. Robbins & Myers Announces Regular Quarterly Cash Dividend
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
9. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
10. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):